Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both (American Journal of Physiology Renal Physiology (2007) 293, (F1935-F1943) DOI:10.1152/ajprenal.00383.2007);Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 6, 2007, Pages

  Mo, Lan ^a   Liaw, Lucy ^c   Evan, Andrew P ^d   Sommer, Andre J ^e   Lieske, John C ^f   Wu, Xue Ru ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Maine Medical Center Research Institute   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MIAMI UNIVERSITY   (United States)

^f Mayo Clinic   (United States)

Author keywords

Kidney stone; Urolithiasis; Uromodulin

Indexed keywords

CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; OSTEOPONTIN; PHOSPHOROUS ACID; TAMM HORSFALL GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CRYSTALLIZATION; EPITHELIUM CELL; GENE SEQUENCE; GENOTYPE; HYPEROXALURIA; INFRARED SPECTROSCOPY; KIDNEY CALCIFICATION; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY PAPILLA; MICROSCOPY; MOUSE; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; URINALYSIS; URINE LEVEL; WESTERN BLOTTING;

EID: 36549078996     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.zh2-5020-corr.2008     Document Type: Erratum

References (38)

1. Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL. Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int 56: 1505-1516, 1999.
2. Bachmann S, Mutig K, Bates J, Welker P, Geist B, Gross V, Luft FC, Alenina N, Bader M, Thiele BJ, Prasadan K, Raffi HS, Kumar S. Renal effects of Tamm-Horsfall protein (uromodulin) deficiency in mice. Am J Physiol Renal Physiol 288: F559-F567, 2005.
3. Bergsland KJ, Kelly JK, Coe BJ, Coe FL. Urine protein markers distinguish stone forming from nonstone forming relatives of calcium stone formers. Am J Physiol Renal Physiol 291: F530-F536, 2006.
4. Bleyer AJ, Hart TC, Shihabi Z, Robins V, Hoyer JR. Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein. Kidney Int 66: 974-977, 2004.
5. Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest 111: 602-605, 2003.
6. Bushinsky DA, Kim M, Sessler NE, Nakagawa Y, Coe FL. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int 45: 58-65, 1994.
7. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 115: 2598-2608, 2005.
8. De Bruijn WC, Boeve ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, van't Noordende JM, Schrder FH. Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation. Scanning Microsc 9: 115-124, 1995.
9. De Yoreo JJ, Qiu SR, Hoyer JR. Molecular modulation of calcium oxalate crystallization. Am J Physiol Renal Physiol 291: F1123-F1131, 2006.
10. Devuyst O, Dahan K, Pirson Y. Tamm-Horsfall protein or uromodulin: new ideas about an old molecule. Nephrol Dial Transplant 20: 1290-1294, 2005.
11. Dou W, Thompson-Jaeger S, Laulederkind SJ, Becker JW, Montgomery J, Ruiz-Bustos E, Hasty DL, Ballou LR, Eastman PS, Srichai B, Breyer MD, Raghow R. Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infections. Am J Physiol Renal Physiol 289: F49-F60, 2005.
12. Evan A, Lingeman J, Coe FL, Worcester E. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69: 1313-1318, 2006.
13. Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Phillips CL, Worcester EM. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69: 2227-2235, 2006.
14. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111: 607-616, 2003.
15. Gao B, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. A polymorphism of the osteopontin gene is related to urinary calcium stones. J Urol 174: 1472-1476, 2005.
16. Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 19: 615-622, 2000.
17. Holmes RP, Assimos DG, Goodman HO. Molecular basis of inherited renal lithiasis. Curr Opin Urol 8: 315-319, 1998.
18. Jiang Z, Asplin JR, Evan AP, Rajendran VM, Velazquez H, Nottoli TP, Binder HJ, Aronson PS. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 38: 474-478, 2006.
19. Khan SR. Pathogenesis of oxalate urolithiasis: lessons from experimental studies with rats. Am J Kidney Dis 17: 398-401, 1991.
20. Khan SR. Animal models of kidney stone formation: an analysis. World J Urol 15: 236-243, 1997.
21. Khan SR. Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res 34: 86-91, 2006.
22. Khan SR, Kok DJ. Modulators of urinary stone formation. Front Biosci 9: 1450-1482, 2004.
23. Kleinman JG, Wesson JA, Hughes J. Osteopontin and calcium stone formation. Nephron Physiol 98: 43-47, 2004.
24. Kumar V, Lieske JC. Protein regulation of intrarenal crystallization. Curr Opin Nephrol Hypertens 15: 374-380, 2006.
25. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 101: 1468-1478, 1998.
26. Lieske JC, Leonard R, Toback FG. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol Renal Fluid Electrolyte Physiol 268: F604-F612, 1995.
27. Lieske JC, Swift H, Martin T, Patterson B, Toback FG. Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc Natl Acad Sci USA 91: 6987-6991, 1994.
28. Mandel N. Mechanism of stone formation. Semin Nephrol 16: 364-374, 1996.
29. Mo L, Huang HY, Zhu XH, Shapiro E, Hasty DL, Wu XR. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 66: 1159-1166, 2004.
30. Mo L, Zhu XH, Huang HY, Shapiro E, Hasty DL, Wu XR. Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am J Physiol Renal Physiol 286: F795-F802, 2004.
31. Moe OW. Kidney stones: pathophysiology and medical management. Lancet 367: 333-344, 2006.
32. Palm F, Carlsson PO. Thick ascending tubular cells in the loop of Henle: regulation of electrolyte homeostasis. Int J Biochem Cell Biol 37: 1554-1559, 2005.
33. Pragasam V, Kalaiselvi P, Subashini B, Sumitra K, Varalakshmi P. Structural and functional modification of THP on nitration: comparison with stone formers THP. Nephron Physiol 99: 28-34, 2005.
34. Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 42: 658-676, 2003.
35. Watts RW. Idiopathic urinary stone disease: possible polygenic aetiological factors. QJM 98: 241-246, 2005.
36. Werness PG, Brown CM, Smith LH, Finlayson B. EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 134: 1242-1244, 1985.
37. Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, Liaw L, Alpers CE, Couser WG, Kleinman JG, Hughes J. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14: 139-147, 2003.
38. Wesson JA, Worcester EM, Wiessner JH, Mandel NS, Kleinman JG. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int 53: 952-957, 1998.